Head of Translational Medicine, Vaccines and Immune Therapies
AstraZeneca
Disclosure(s): AstraZeneca: Employee of AstraZeneca and may own AstraZeneca stock or stock options.
Katie Streicher, PhD, leads the Translational Medicine team in Vaccines and Immune Therapies at AstraZeneca. The Translational Medicine team is responsible for bridging Discovery research with clinical development to incorporate key endpoints into both early and late-stage clinical studies and deliver the scientific data critical for progressing the portfolio. Katie has a Ph.D. in Immunology with 15+ years of industry experience leading cross-functional drug development teams and conducting cutting-edge translational research in Oncology, Autoimmunity, and Infectious diseases. Katie has authored over 40 peer-reviewed publications, has 9 patents in precision medicine and biomarker discovery, and has been closely involved in the health authority submissions/ approvals of 3 marketed products.